Benjamin Conti

Benjamin Conti practices at St. Tammany Parish Hospital in Covington, Louisiana, part of St. Tammany Health System.

Benjamin Conti's NPI, 1649774787, was assigned on March 22, 2018. Benjamin Conti holds Louisiana license 326904.

Benjamin Conti's primary practice is St. Tammany Parish Hospital, at 1202 S Tyler Street, Covington, LA 70433 in St. Tammany Parish. The practice phone is (985) 898-4000.

Benjamin Conti's primary practice is St. Tammany Parish Hospital in Covington, Louisiana, part of St. Tammany Health System. The medical group on file is St. Tammany Health System. Dmand AI also links Benjamin Conti to 1 more clinical lab, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Benjamin Conti practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Benjamin Conti's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Benjamin Conti is licensed in Louisiana.

CMS data shows 340 Medicare services from Benjamin Conti across 2 procedure codes in 2024, for 335 Medicare patients. Medicare paid $41,372 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 335 Medicare patients who saw Benjamin Conti in 2024. The largest group is 65 to 74, with 134 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Benjamin Conti's median patient age at 53, with 59% women.

In 2024, Benjamin Conti wrote 325 Medicare Part D claims for 202 patients. 96% of them were for generic drugs. CMS names the drug for 257 of them, across 13 drugs with 11 or more claims each, at $2,258 in total drug cost. In 2023, CMS named 138 claims across 8 drugs.

CMS Open Payments shows 3 general payments to Benjamin Conti from 2 drug and device companies from 2021 to 2024. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $36.